Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
Meng CY, Sun S, Liang Y, Xu H, Zhang C, Zhang M, Wang FS, Fu YX, Peng H.
Gut. 2023 Aug;72(8):1544-1554. doi: 10.1136/gutjnl-2022-327059. Epub 2022 Oct 31.
Construction of a Delivery Platform for Vaccine Based on Modified Nanotubes: Sustainable Prevention against Plant Viral Disease, Simplified Preparation Method, and Protection of Plasmid.
Liu S, Su C, Zhang D, Song Z, Wang X, Wang J, Yuan X.
ACS Appl Mater Interfaces. 2023 Sep 20;15(37):44541-44553. doi: 10.1021/acsami.3c09168. Epub 2023 Sep 6.
Update of Perinatal Human Immunodeficiency Virus Type 1 Transmission in France: Zero Transmission for 5482 Mothers on Continuous Antiretroviral Therapy From Conception and With Undetectable Viral Load at Delivery.
Sibiude J, Le Chenadec J, Mandelbrot L, Hoctin A, Dollfus C, Faye A, Bui E, Pannier E, Ghosn J, Garrait V, Avettand-Fenoel V, Frange P, Warszawski J, Tubiana R.
Clin Infect Dis. 2023 Feb 8;76(3):e590-e598. doi: 10.1093/cid/ciac703.
[HIV and pregnancy].
Zweifel VB, Berger C, Nadal D, Grawe C.
Ther Umsch. 2014 Aug;71(8):498-502. doi: 10.1024/0040-5930/a000543.
COVID-19 pandemic: A global health burden.
Akande OW, Akande TM.
Niger Postgrad Med J. 2020 Jul-Sep;27(3):147-155. doi: 10.4103/npmj.npmj_157_20.
Gene Therapy Cargoes Based on Viral Vector Delivery.
Lundstrom K.
Curr Gene Ther. 2023;23(2):111-134. doi: 10.2174/1566523222666220921112753.
Antiviral therapy for human rabies.
Appolinario CM, Jackson AC.
Antivir Ther. 2015;20(1):1-10. doi: 10.3851/IMP2851. Epub 2014 Aug 26.
Nanotechnology for COVID-19: Therapeutics and Vaccine Research.
Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Martinez-Chapa SO.
ACS Nano. 2020 Jul 28;14(7):7760-7782. doi: 10.1021/acsnano.0c04006. Epub 2020 Jun 29.
Delivery in pregnant women infected with SARS-CoV-2: A fast review.
Parazzini F, Bortolus R, Mauri PA, Favilli A, Gerli S, Ferrazzi E.
Int J Gynaecol Obstet. 2020 Jul;150(1):41-46. doi: 10.1002/ijgo.13166. Epub 2020 May 1.
Engineered extracellular vesicles for delivering functional Cas9/gRNA to eliminate hepatitis B virus cccDNA and integration.
Zeng W, Zheng L, Li Y, Yang J, Mao T, Zhang J, Liu Y, Ning J, Zhang T, Huang H, Chen X, Lu F.
Emerg Microbes Infect. 2024 Dec;13(1):2284286. doi: 10.1080/22221751.2023.2284286. Epub 2023 Dec 30.
